Literature DB >> 12612795

Structural alterations of prosthetic meshes in humans.

A Coda1, R Bendavid, F Botto-Micca, M Bossotti, A Bona.   

Abstract

The use of prosthetic mesh in abdominal wall hernia surgery is a well-accepted practice. What is not settled, however, is the type of prosthesis that best suits the purpose. The narrow choice today means a prosthesis of polyester or polypropylene. These are available in many designs, configuration of weave, thickness of weave and strand, and size of pore. There has been a pervasive feeling that these materials "shrink". To what extent they do has not been accurately defined. This study was designed to measure such "shrinkage". Interestingly, our measurements revealed that prosthetic meshes could "expand" as well as "shrink". The extent to which they do varies between -40% and 58.5%. Whereas it was felt that fibrocyte activity and its eventual scar formation accounted for the "shrinkage" of the mesh, we have discovered that structural alterations in the size of the mesh pores can be affected by distilled water, saline, blood, formalin, bleach, as well as in vivo implantation. Prosthetic meshes are, therefore, not the inert materials they are claimed to be and can expand as well as shrink. We have, unfortunately, not been able to correlate the degree or direction of change to any known parameter.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12612795     DOI: 10.1007/s10029-002-0089-6

Source DB:  PubMed          Journal:  Hernia        ISSN: 1248-9204            Impact factor:   4.739


  29 in total

1.  Searching for the best polypropylene mesh to be used in bowel contamination.

Authors:  A Díaz-Godoy; M A García-Ureña; J López-Monclús; V Vega Ruíz; D Melero Montes; N Erquinigo Agurto
Journal:  Hernia       Date:  2010-12-09       Impact factor: 4.739

2.  Histological studies of monofilament and multifilament polypropylene mesh implants demonstrate equivalent penetration of macrophages between fibrils.

Authors:  John Papadimitriou; Peter Petros
Journal:  Hernia       Date:  2004-11-19       Impact factor: 4.739

3.  Precoating of alloplastic materials with living human fibroblasts--a feasibility study.

Authors:  M Kapischke; K Prinz; J Tepel; J Tensfeldt; T Schulz
Journal:  Surg Endosc       Date:  2005-05-04       Impact factor: 4.584

4.  Comparative investigation of alloplastic materials for hernia repair with improved methodology.

Authors:  M Kapischke; K Prinz; J Tepel; J Tensfeldt; T Schulz
Journal:  Surg Endosc       Date:  2005-07-14       Impact factor: 4.584

5.  Tensile strength and host response towards different polypropylene implant materials used for augmentation of fascial repair in a rat model.

Authors:  Maja L Konstantinovic; Eline Pille; Marta Malinowska; Eric Verbeken; Dirk De Ridder; Jan Deprest
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-10-10

6.  A lightweight polypropylene mesh (TiMesh) for laparoscopic intraperitoneal repair of abdominal wall hernias: comparison of biocompatibility with the DualMesh in an experimental study using the porcine model.

Authors:  C Schug-Pass; C Tamme; A Tannapfel; F Köckerling
Journal:  Surg Endosc       Date:  2006-01-21       Impact factor: 4.584

7.  Recurrence following endoscopic extraperitoneal inguinal hernioplasty.

Authors:  H Lau
Journal:  Hernia       Date:  2007-07-03       Impact factor: 4.739

Review 8.  Polypropylene mesh and the host response.

Authors:  Hiren Patel; Donald R Ostergard; Gina Sternschuss
Journal:  Int Urogynecol J       Date:  2012-03-20       Impact factor: 2.894

9.  Repair of the inguinal hernia using the hernia sac to correct the abdominal wall defect.

Authors:  A Laizo; F E da Fonseca Delgado; M R Terzella; A Lázaro da Silva
Journal:  G Chir       Date:  2013 Jul-Aug

10.  Polypropylene as a reinforcement in pelvic surgery is not inert: comparative analysis of 100 explants.

Authors:  Arnaud Clavé; Hannah Yahi; Jean-Claude Hammou; Suzelei Montanari; Pierre Gounon; Henri Clavé
Journal:  Int Urogynecol J       Date:  2010-01-06       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.